EdgeMarket › What Carlyle Group Inc. reported owning
What Carlyle Group Inc. reported owning
As filed on Form 13F for the quarter ending 2026-03-31, up to 45 days after that date. Long-only US-listed equity — shorts, bonds, cash and non-US listings are not on the form, so this is one leg of the book, not the book.
Reported value
10.6BPositions
20Quarter
2026-03-31Shown below
20largest by value
| holding | value | % of book | shares | price | 1y |
|---|---|---|---|---|---|
| MDLN Medline Inc. | 8.3B | 78.4% | 187.1M | 34.26 | — |
| SARO StandardAero, Inc. | 2.2B | 20.6% | 84.6M | 25.06 | -5.9% |
| PHAT Phathom Pharmaceuticals, Inc. | 38.8M | 0.4% | 3.5M | 8.87 | -16.6% |
| PONY Pony AI Inc. | 22.3M | 0.2% | 2.4M | 8.23 | -44.7% |
| INVH Invitation Homes Inc. | 16.5M | 0.2% | 664.1K | 30.11 | -1.4% |
| CUBE CubeSmart | 8.1M | 0.1% | 220.5K | 40.89 | +2.3% |
| QTTB Q32 Bio Inc. | 7.1M | 0.1% | 1.1M | 15.97 | +763.2% |
| GETY Getty Images Holdings, Inc. | 4.9M | 0.0% | 6.2M | 0.26 | -85.6% |
| SPRB SPRUCE BIOSCIENCES, INC. | 2.5M | 0.0% | 38.6K | 51.58 | +65523.4% |
| FWRD FORWARD AIR CORP | 1.8M | 0.0% | 107.2K | 18.11 | -34.8% |
| ACET Adicet Bio, Inc. | 1.3M | 0.0% | 184.3K | 9.19 | -10.3% |
| DNUT Krispy Kreme, Inc. | 1.2M | 0.0% | 340.7K | 3.59 | +2.6% |
| OKUR OnKure Therapeutics, Inc. | 1.1M | 0.0% | 269.9K | 3.94 | +44.3% |
| JSPR Jasper Therapeutics, Inc. | 934.2K | 0.0% | 1.1M | 0.72 | -74.9% |
| SPWR SunPower Inc. | 550.1K | 0.0% | 433.2K | 0.30 | -81.7% |
| HTFL Heartflow, Inc. | 497.3K | 0.0% | 20.4K | 49.75 | +69.7% |
| SYRE Spyre Therapeutics, Inc. | 485.2K | 0.0% | 9.6K | 106.49 | +551.3% |
| NABL N-able, Inc. | 437.7K | 0.0% | 93.7K | 3.63 | -51.8% |
| XCUR EXICURE, INC. | 239.6K | 0.0% | 56.3K | 1.15 | -81.3% |
| HOOD Robinhood Markets, Inc. | 234.0K | 0.0% | 3.4K | 108.13 | +2.6% |
A position that grew quarter on quarter may simply reflect a higher price: if the stock rose 40% and the manager did nothing, the reported value rose 40%. Reading that as accumulation is reading the price back to yourself. More on that →
The whole archive is one click away.
Screener, filings, insider flow, backtests and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →